share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Desmond-Hellmann Susan

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Desmond-Hellmann Susan

辉瑞 | 4:持股变动声明-董事 Desmond-Hellmann Susan
美股sec公告 ·  04/26 13:24
Moomoo AI 已提取核心信息
Susan Desmond-Hellmann, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As such, the impact of this event on Desmond-Hellmann's holdings and on Pfizer's stock is currently unclear.
Susan Desmond-Hellmann, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As such, the impact of this event on Desmond-Hellmann's holdings and on Pfizer's stock is currently unclear.
辉瑞公司 [PFE] 的举报人苏珊·戴斯蒙德-赫尔曼于2024年4月25日参与了一笔交易。该交易的具体细节,包括行动类型、状态、股票数量、股票性质、交易价格和交易后持有量,未在公告中披露。因此,目前尚不清楚该事件对戴斯蒙德-赫尔曼持股和辉瑞股票的影响。
辉瑞公司 [PFE] 的举报人苏珊·戴斯蒙德-赫尔曼于2024年4月25日参与了一笔交易。该交易的具体细节,包括行动类型、状态、股票数量、股票性质、交易价格和交易后持有量,未在公告中披露。因此,目前尚不清楚该事件对戴斯蒙德-赫尔曼持股和辉瑞股票的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息